Directed Topical Drug Delivery for Treatment for PASC Hyposmia

Summary

This is a phase II randomized, double-blinded, placebo-controlled study to evaluate the efficacy of topical intranasal treatment of beclomethasone vs. placebo for improved olfactory function.

Timeline

Start

2023-09-05

Primary completion

2024-10-07

Completion

2024-10-07

Drugs

Indications